PATIENT WITH HUNTINGTON’S DISEASE, PRESENTING AS PSYCHOTIC DISORDER – CASE REPORT

  • Lilijana Horvat Psihiatrična klinika Ljubljana, Studenec 48, 1260 Ljubljana Polje
  • Mojca Z Dernovšek Psihiatrična klinika Ljubljana, Studenec 48, 1260 Ljubljana Polje
  • Janez Mlakar Psihiatrična klinika Ljubljana, Studenec 48, 1260 Ljubljana Polje
Keywords: Huntington’s disease, psychotic disorder, differential diagnosis, therapy, case report

Abstract

Background. Huntington’s disease (HD) is rare. It usually starts with choreatic movements and cognitive impairment, progressing to dementia. A case report revealing diagnostic difficulties in a patient with HD, which began as psychotic disorder is presented. Patient was treated for almost five years in psychiatric outpatients’ service and psychiatric hospital due to a treatment-resistant psychotic disorder. Choreatic movements emerged during the fourth year of the treatment and were misdiagnosed as tardive dyskinesia. Prominent deterioration of cognitive functions demanded further diagnostics. With genetic tests HD was diagnosed.
Conclusions. The start of HD with psychotic disorder is less common. In patients with treatment-resistant psychoses other somatic disorders should be considered.

Downloads

Download data is not yet available.

References

Marsden CD, Fowler TJ. Clinical neurology. London: Edward Arnold 1998: 217.
Andrew SE, Goldberg YP, Kremer B et al. Huntington disease without CAG expansion: phenocopies or errors in assignment? Am J Hum Genet 1994; 54: 852–63.
Andrew SE, Goldberg YP, Kremer B et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease. Nat Genet 1993; 4: 398–403.
Cote L, Crutcher MD. The basal ganglia. In: Kandel ER, Schwartz JH, Jessel TM. Principles of neural science. 3th ed. Norwalk: Appleton & Lange, 1991: 647–59.
Goldberg YP, Andrews SE, Clarke LA, Hayden MR. A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington disease. Hum Mol Genet 1993; 6: 635–6.
Savvopoulos S, Golaz J, Bouras C, Constantinidis J, Tissot R. Huntington chorea. Anatomoclinical and genetic study of 17 cases. Encephale 1990; 16: 251–9.
Louis Ed, Anderson KE, Moskowitz C, Thorne DZ, Marder K. Dystoniapredominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults. Arch Neurol 2000; 57: 1326–30.
Folstein S, Abbott MH, Chase GA, Jensen BA, Folstein MF. The association of affective disorder with Huntington’s disease in a case series and in families. Psychol Med 1983; 13: 537–42.
Karno M, Norquist GS. Schizophrenia: epidemiology. In: Kaplan HI, Sadock BJ. Comprehensive textbook of psychiatry. 6th ed. Vol. 1. Baltimore: Williams & Wilkins, 1995: 902–10.
Peuskens J. The evolving definition of treatment resistance. J Clin Psychiatry 1999; 60: Suppl 12: 4–8.
Aitchison KJ, Meehan K, Murray RM. First episode psychosis. London: Martin Dunitz, 1999: 23.
Heilman KM, Bowers D, Valenstein E. Emotional disorders associated with neurological diseases. In: Heilman KM, Valenstein E. Clinical neuropsychology. 2nd ed. New York: Oxford University Press, 1985: 377–96.
Khot V, Wyatt RJ. Not all that moves is tardive dyskinesia. Am J Psychiatry 1991; 148: 661–6.
Casey DE. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia. Schizophr Res 1991; 4: 109–20.
Meltzer HY. Treatment-resistant schizophrenia – the role of clozapine. Curr Med Res Opin 1997; 14: 1–20.w
Published
2017-04-16
How to Cite
1.
Horvat L, Dernovšek M, Mlakar J. PATIENT WITH HUNTINGTON’S DISEASE, PRESENTING AS PSYCHOTIC DISORDER – CASE REPORT. TEST ZdravVestn [Internet]. 16Apr.2017 [cited 5Aug.2024];70(6). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/2566
Section
Case report, short scientific article